Stocks and Investing Stocks and Investing
Thu, November 21, 2019
Wed, November 20, 2019

Ying Huang Reiterated (VRTX) at Strong Buy with Increased Target to $245 on, Nov 20th, 2019


Published on 2024-10-26 18:29:28 - WOPRAI, Ying Huang
  Print publication without navigation


Ying Huang of B of A Securities, Reiterated "Vertex Pharmaceuticals Incorporated" (VRTX) at Strong Buy with Increased Target from $235 to $245 on, Nov 20th, 2019.

Ying has made no other calls on VRTX in the last 4 months.



There are 7 other peers that have a rating on VRTX. Out of the 7 peers that are also analyzing VRTX, 1 agrees with Ying's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Alan Carr of "Needham" Downgraded from Strong Buy to Hold on, Thursday, August 1st, 2019


These are the ratings of the 6 analyists that currently disagree with Ying


  • Alethia Young of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $229 on, Tuesday, November 19th, 2019
  • Edward Tenthoff of "Piper Sandler" Maintained at Buy with Increased Target to $247 on, Thursday, October 31st, 2019
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Increased Target to $250 on, Thursday, October 31st, 2019
  • Paul Matteis of "Stifel" Maintained at Strong Buy with Increased Target to $229 on, Thursday, October 31st, 2019
  • Robyn Karnauskas of "Citigroup" Maintained at Strong Buy with Increased Target to $225 on, Tuesday, October 22nd, 2019
  • Evan Seigerman of "Credit Suisse" Maintained at Buy with Increased Target to $213 on, Thursday, August 1st, 2019
Contributing Sources